MRP ₹91.5
(Inclusive of all Taxes)
₹13.7 Cashback (15%)
%2520JP_OneCard.png?tr=q-85,f-webp,w-50,dpr-1,c-at_max){kind=small}
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
``` :கலவை :
LANSOPRAZOLE-15MG
உற்பத்தியாளர்/சந்தைப்படுத்துபவர் :
சிப்லா லிமிடெட்
நுகர்வு வகை :
வாய்வழி
வருமானக் கொள்கை :
திரும்பப் பெற முடியாது
அல்லது அதற்குப் பிறகு காலாவதியாகும் :
Jan-27
Have a query?
Drug-Drug Interactions
LansoprazoleRilpivirine
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
LansoprazoleRilpivirine
Critical
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet can make Rilpivirine less effective by reducing its absorption in the body.
How to manage the interaction:
Taking Rilpivirine with Lanzira 15 mg Orally Disintegrating Tablet can result in an interaction, but can be taken if prescribed by the doctor. Do not discontinue any medication without consulting a doctor.
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet can make Rilpivirine less effective by reducing its absorption in the body.
How to manage the interaction:
Taking Rilpivirine with Lanzira 15 mg Orally Disintegrating Tablet can result in an interaction, but can be taken if prescribed by the doctor. Do not discontinue any medication without consulting a doctor.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Taking Tacrolimus with Lanzira 15 mg Orally Disintegrating Tablet may increase the blood levels of Tacrolimus and this may lead to high sugars, infections, kidney problems, hyperkalemia (high blood levels of potassium), visual disturbances, and high blood pressure.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Tacrolimus together can possibly result in an interaction, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience irregular heart rhythm, muscle pains, tremors (shaking hands & legs), and seizures(fits). Do not discontinue any medications without consulting a doctor.
Taking Tacrolimus with Lanzira 15 mg Orally Disintegrating Tablet may increase the blood levels of Tacrolimus and this may lead to high sugars, infections, kidney problems, hyperkalemia (high blood levels of potassium), visual disturbances, and high blood pressure.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Tacrolimus together can possibly result in an interaction, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience irregular heart rhythm, muscle pains, tremors (shaking hands & legs), and seizures(fits). Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Co-administration of Atazanavir with Lanzira 15 mg Orally Disintegrating Tablet may make atazanavir less effective against HIV.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and atazanavir together can result in an interaction, it can be taken if a doctor has prescribed it. Do not discontinue any medications without a doctor's advice.
Co-administration of Atazanavir with Lanzira 15 mg Orally Disintegrating Tablet may make atazanavir less effective against HIV.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and atazanavir together can result in an interaction, it can be taken if a doctor has prescribed it. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Taking Lanzira 15 mg Orally Disintegrating Tablet with Dapsone may decrease the level or effect of Dapsone.
How to manage the interaction:
Although there is a possible interaction between Dapsone and Lanzira 15 mg Orally Disintegrating Tablet, you can take these medicines together if prescribed by a doctor. Do not stop using any medications without consulting a doctor.
Taking Lanzira 15 mg Orally Disintegrating Tablet with Dapsone may decrease the level or effect of Dapsone.
How to manage the interaction:
Although there is a possible interaction between Dapsone and Lanzira 15 mg Orally Disintegrating Tablet, you can take these medicines together if prescribed by a doctor. Do not stop using any medications without consulting a doctor.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet with Cilostazol may increase the risk of side effects.
How to manage the interaction:
Taking Lanzira 15 mg Orally Disintegrating Tablet with Cilostazol together can result in an interaction, it can be taken if a doctor has advised it. However, contact a doctor immediately if you experience any symptoms such as dizziness, lightheadedness, fainting, breathing difficulty, or rapid heartbeat. Do not discontinue any medications without consulting a doctor.
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet with Cilostazol may increase the risk of side effects.
How to manage the interaction:
Taking Lanzira 15 mg Orally Disintegrating Tablet with Cilostazol together can result in an interaction, it can be taken if a doctor has advised it. However, contact a doctor immediately if you experience any symptoms such as dizziness, lightheadedness, fainting, breathing difficulty, or rapid heartbeat. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet with Gefitinib may interfere with the absorption of Gefitinib and reduce its effectiveness.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Gefitinib together can result in an interaction, it can be taken if a doctor has prescribed it. To decrease the effects of the interaction, it is advised to take gefitinib either 12 hours before or 12 hours after Lanzira 15 mg Orally Disintegrating Tablet. Do not discontinue any medications without a doctor's advice.
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet with Gefitinib may interfere with the absorption of Gefitinib and reduce its effectiveness.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Gefitinib together can result in an interaction, it can be taken if a doctor has prescribed it. To decrease the effects of the interaction, it is advised to take gefitinib either 12 hours before or 12 hours after Lanzira 15 mg Orally Disintegrating Tablet. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
When Lanzira 15 mg Orally Disintegrating Tablet and Citalopram are taken together, Lanzira 15 mg Orally Disintegrating Tablet may increase the blood levels of citalopram and increase the risk of side effects, such as an irregular heart rhythm that may be serious.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Citalopram together can result in an interaction, it can be taken if a doctor has prescribed it. However, consult a doctor if you experience sudden dizziness, lightheadedness, fainting, breathing difficulty, or fast or pounding heartbeats. Do not discontinue any medications without a doctor's advice.
When Lanzira 15 mg Orally Disintegrating Tablet and Citalopram are taken together, Lanzira 15 mg Orally Disintegrating Tablet may increase the blood levels of citalopram and increase the risk of side effects, such as an irregular heart rhythm that may be serious.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Citalopram together can result in an interaction, it can be taken if a doctor has prescribed it. However, consult a doctor if you experience sudden dizziness, lightheadedness, fainting, breathing difficulty, or fast or pounding heartbeats. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Taking Lanzira 15 mg Orally Disintegrating Tablet with Pazopanib can reduce the effectiveness of Pazopanib.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Pazopanib together can result in an interaction, it can be taken if a doctor has advised it. However, consult a doctor if you experience any unusual symptoms. Do not stop using any medications without a doctor's advice.
Taking Lanzira 15 mg Orally Disintegrating Tablet with Pazopanib can reduce the effectiveness of Pazopanib.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Pazopanib together can result in an interaction, it can be taken if a doctor has advised it. However, consult a doctor if you experience any unusual symptoms. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet can make Dacomitinib less effective by reducing its absorption and lowering its concentration in the blood.
How to manage the interaction:
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet with Dacomitinib can result in an interaction, but it can be taken if a doctor has advised it. Do not discontinue any medications without consulting to a doctor.
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet can make Dacomitinib less effective by reducing its absorption and lowering its concentration in the blood.
How to manage the interaction:
Co-administration of Lanzira 15 mg Orally Disintegrating Tablet with Dacomitinib can result in an interaction, but it can be taken if a doctor has advised it. Do not discontinue any medications without consulting to a doctor.
Severe
How does the drug interact with Lanzira 15 mg Orally Disintegrating Tablet:
Co-administration of Dasatinib together with Lanzira 15 mg Orally Disintegrating Tablet may decrease the effectiveness of Dasatinib.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Dasatinib together can result in an interaction, it can be taken if a doctor has prescribed it. In case of any unusual side effects, consult a doctor. Do not discontinue any medications without a doctor's advice.
Co-administration of Dasatinib together with Lanzira 15 mg Orally Disintegrating Tablet may decrease the effectiveness of Dasatinib.
How to manage the interaction:
Although taking Lanzira 15 mg Orally Disintegrating Tablet and Dasatinib together can result in an interaction, it can be taken if a doctor has prescribed it. In case of any unusual side effects, consult a doctor. Do not discontinue any medications without a doctor's advice.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Lanzira 15 mg Orally Disintegrating Tablet Substitute
Junior Lanzomid 15mg Tablet
by Others
₹5.31per tabletJunior Dayrabe 15mg Tablet
by Others
₹5.49per tabletLanofast-Junior Tablet 15's
by Others
₹6.00per tabletJunior Lgerd 15mg Tablet DT
by Others
₹6.21per tabletJunior Bravia Tablet 10's
by AYUR
₹6.26per tablet
மது
பொருந்தாது
-
கர்ப்பம்
பொருந்தாது
-
தாய்ப்பால்
பொருந்தாது
-
ஓட்டுநர்
பொருந்தாது
-
கல்லீரல்
உங்கள் மருத்துவரை அணுகவும்
உங்கள் குழந்தைக்கு கல்லீரல் பாதிப்பு இருந்தால் அல்லது இது தொடர்பாக ஏதேனும் கவலைகள் இருந்தால் மருத்துவரை அணுகவும்.
சிறுநீரகம்
உங்கள் மருத்துவரை அணுகவும்
உங்கள் குழந்தைக்கு சிறுநீரக பிரச்சினைகள் இருந்தால் மருத்துவரை அணுகவும்.
குழந்தைகள்
பரிந்துரைக்கப்பட்டால் பாதுகாப்பானது
மருத்துவர் பரிந்துரைத்தால் Lanzira 15 mg Orally Disintegrating Tablet 10's குழந்தைகளுக்கு பாதுகாப்பானது. உங்கள் மருத்துவர் குழந்தையின் நிலை மற்றும் வயதை அடிப்படையாகக் கொண்டு இந்த மருந்தின் அளவை பரிந்துரைக்கலாம்.
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
